Filing Details

Accession Number:
0001170362-14-000006
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-14 19:34:17
Reporting Period:
2014-05-12
Filing Date:
2014-05-14
Accepted Time:
2014-05-14 19:34:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1080709 Arena Pharmaceuticals Inc ARNA Pharmaceutical Preparations (2834) 232908305
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1170362 W Steven Spector C/O Arena Pharmaceuticals, Inc.
6154 Nancy Ridge Drive
San Diego CA 92121
Evp, General Counsel & Sec No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-05-12 45,000 $1.49 147,187 No 4 M Direct
Common Stock Disposition 2014-05-12 45,000 $7.05 102,187 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2014-05-12 45,000 $0.00 45,000 $1.49
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
145,000 2021-03-15 No 4 M Direct
Footnotes
  1. The amount includes shares purchased under Arena's employee stock purchase plan prior to the reported transaction.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
  3. The options vest in four equal annual installments, and are exercisable once vested. The first, second and third installments became exercisable on March 15, 2012, 2013 and 2014, respectively, and the fourth installment vests on March 15, 2015.